Lindbrook Capital’s NEOPHOTONICS CORP NPTN Stock Holding History

Lindbrook Capital’s Portfolio NPTN Stock Details NPTN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-136	Closed	-$1K	–	1938
2020 Q1	$1K	Buy	+136	New	+$1.01K	﹤0.01%	1636

Other funds holding NPTN

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Lindbrook Capital's NPTN Position: Q2 2020 in Review

Lindbrook Capital sold out of NEOPHOTONICS CORP (NPTN) in Q2 2020, closing a stake of 136 shares — an estimated $1K sold.

Lindbrook Capital first reported a position in NPTN in Q1 2020 and held it in 1 quarter. The position peaked at $1K in Q1 2020. 163 funds tracked by Wall St. Rank hold NPTN as of Q2 2020.

Lindbrook Capital reported no remaining NEOPHOTONICS CORP position as of Q2 2020 after selling out during the quarter.
Lindbrook Capital sold 136 NEOPHOTONICS CORP shares in Q2 2020, an estimated $1K.
Lindbrook Capital first reported a position in NEOPHOTONICS CORP in Q1 2020 and held it in 1 quarter.
Lindbrook Capital's NEOPHOTONICS CORP position peaked at $1K in Q1 2020.
163 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q2 2020.

Based on Lindbrook Capital's 13F filing for Q2 2020, filed 27 Jul 2020.